Sigachi Industries Limited, one of India’s leading manufacturers of pharmaceutical excipients, APIs, and speciality ingredients, has commenced civil works for its latest phase of capacity expansion—an advanced 12,000 metric tonnes per annum (MTPA) Microcrystalline Cellulose (MCC) facility at its Dahej SEZ unit in Gujarat. This strategic initiative aligns with the company’s long-term commitment to operational resilience, a safety-first design approach, and continued global leadership in the excipient industry.Despite ongoing investigations into the recent tragic incident at its Pashamylaram unit, Sigachi remains focused on future-ready development. The Dahej MCC project highlights the company’s determination to emerge stronger with upgraded systems, internationally benchmarked safety measures, and increased production capacity aimed at ensuring uninterrupted supply to its global clientele.Key Highlights of the Expansion Strategy:Capacity Boost: An additional 12,000 MTPA MCC capacity will be added at Dahej SEZ, expected to be operational within nine months.Safety & Design Excellence: The new spray dryer system is being developed in collaboration with reputed equipment manufacturers and safety experts.Total Capacity: Sigachi’s total installed MCC capacity will rise to 30,000 MTPA, strengthening its position as the largest manufacturer in India and among the global leaders.Business Continuity: The new Dahej capacity, along with enhanced output from existing units in Jhagadia and Dahej SEZ, will support continued, disruption-free supply to customers.Statement from Amit Raj Sinha, MD & CEO:“The incident at Pashamylaram was deeply saddening. Yet, Sigachi stands resolute—rooted in its values, open to learning, and committed to rebuilding stronger. This new capacity at Dahej is a testament to our resilience. It’s not merely about increased volumes but about establishing the world’s safest and most dependable excipient manufacturing ecosystem.”Acknowledgement of Stakeholder Support:Sigachi has expressed sincere gratitude to its customers in over 65 countries, many of whom extended messages of support during this challenging time. The empathy shown by the global pharmaceutical and nutrition community has reaffirmed the company’s mission and values. Sigachi also appreciates the unwavering support from its supply chain partners, equipment vendors, and domain experts who are contributing to the reconstruction of systems with world-class safety and operational integrity.